Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Health Outcomes of Patients With Stable Chronic Disease Managed With a Healthcare Kiosk

21 de junio de 2018 actualizado por: Grace Ng Beng Hua, SingHealth Polyclinics

A Randomized Controlled Trial to Evaluate the Health Outcomes of Patients With Stable Chronic Disease Managed With a Healthcare Kiosk

The chronic disease burden is increasing worldwide leading to a rise in the demand for primary healthcare and a shortage of primary care physicians. Addressing this shortage entails a multi-prong approach with innovations in care delivery, greater use of healthcare technology, and more efficient use of all healthcare providers on the care team.

We previously developed an interactive self-service healthcare kiosk (Self-empowering and enabling kiosk - SEEK® MyHealthKiosk) for the management of patients with stable chronic disease in the primary care setting. A feasibility study using SEEK showed high levels of acceptance and satisfaction from patients and healthcare providers.

The aim of this follow-up study is to evaluate the health outcomes of patients with stable chronic disease who are on kiosk management compared to patients who are on routine management by nurse clinicians. We hypothesize that patients who are managed by the kiosk continue to maintain good disease control that are comparable to patients who are managed by a nurse clinician.

Descripción general del estudio

Estado

Desconocido

Intervención / Tratamiento

Descripción detallada

Patients who seek primary healthcare vary in their time and resource requirements. Patients with acute medical conditions or poorly controlled chronic disease typically require more time and attention compared to patients with stable chronic disease.

Patients with chronic disease routinely make follow-up visits to their primary care provider for assessment of their chronic disease status and for changes to their medications as necessary. Patients with well-controlled stable chronic disease may go through several visits to their primary care provider in 3 or 4-monthly intervals with little or no change to their medication regimen. These patients have to wait in line with the rest of the patient crowd for a doctor's consultation before getting their regular supply of medications. We hence saw the potential of replacing some of these physician visits with an automated healthcare kiosk so that if the disease condition of such patients remained stable, they can continue on their current medications without having to see a doctor.

We previously described the feasibility of using an automated healthcare kiosk (SEEK® MyHealthKiosk) for the management of patients with stable chronic disease in the primary care setting. We propose a follow-up study to show equivalence of health outcomes for patients managed with SEEK compared to the current standard of care. The study will be a 2-armed randomized controlled trial of 120 patients with stable chronic disease on 4-monthly follow-up visits over a 12-month period. Patients will be assigned randomly to intervention or control groups to receive kiosk or nurse management respectively. The main primary outcome measure is the overall chronic disease control of the patients. Other primary outcome measures are the blood pressure and low-density lipoprotein cholesterol levels for patients without diabetes; and blood pressure, low-density lipoprotein cholesterol and hemoglobin A1c levels for patients with diabetes. Secondary outcome measures are visit duration, patient satisfaction with the management process, health-related quality of life, and the occurrence of any adverse event.

The potential benefits from the use of SEEK are:

  1. Appropriate stratification of patient care needs so that more time and resources can be channeled to patients with complex or acute needs;
  2. Patient empowerment in the management of their chronic health conditions, with flexibility of self-care and monitoring and decreased dependency on healthcare providers;
  3. Substitution of nurse clinicians for the management of stable chronic disease;
  4. Reduction in the number of doctor visits per year for patients with stable chronic disease.

Tipo de estudio

Intervencionista

Inscripción (Anticipado)

120

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Singapore, Singapur
        • Reclutamiento
        • SingHealth Polyclinics - Punggol
        • Contacto:
          • Executive
          • Número de teléfono: 6643 6969

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

21 años a 75 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • are between the ages of 21 and 75 years
  • have at least one chronic medical condition that includes hypertension, hyperlipidemia, diabetes mellitus
  • have blood pressure, low-density lipoprotein cholesterol (LDL-C) and HbA1c levels within the recommended targets according to the Ministry of Health Singapore clinical practice guidelines for their current and last follow-up visits
  • are able to provide informed consent.

Exclusion Criteria:

  • have serum creatinine more than 140 mmol/L (from tests done within the past year)
  • have serum potassium less than 3.5 mmol/L or more than 5 mmol/L (from tests done within the past year)
  • have overt proteinuria (urine protein:creatinine ratio more than 0.5)
  • were discharged from hospital or specialist follow-up within the last 6 months
  • have any pending laboratory or investigation result
  • are scheduled for any laboratory investigation within the next 4 months (except HbA1c or panel test)
  • have any new complaint related to their chronic medical conditions
  • have a known history of white coat hypertension

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Otro
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Kiosk intervention group

SEEK automates the management of patients with stable well-controlled chronic disease. SEEK has the following capabilities:

  • Collects patient information using patient-specific identification
  • Prompts the user for answers to screening questions for acute conditions
  • Measures relevant physiological parameters: blood pressure, height, weight; and calculates body mass index
  • Triages patients based on responses to screening questions, physiological parameters and blood test results
  • Provides recommendations to the patient on the care plan, self management and lifestyle choices
Otros nombres:
  • SEEK® MyHealthKiosk
Sin intervención: Nurse clinician control group

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Periodo de tiempo
Presión arterial
Periodo de tiempo: 12 meses
12 meses
Hemoglobina a1c
Periodo de tiempo: 12 meses
12 meses
Disease control
Periodo de tiempo: 12 months
12 months
Low-density lipoprotein cholesterol
Periodo de tiempo: 12 months
12 months

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Eventos adversos
Periodo de tiempo: 12 meses
12 meses
Visit duration
Periodo de tiempo: 8 months
8 months
Patient satisfaction questionnaire
Periodo de tiempo: 12 months
The following areas of patient satisfaction will be scored on a Likert scale: convenience of visit schedule, location of kiosk or nurse consultation, appropriateness of management, duration of time spent in kiosk usage or nurse consultation, and the replacement of a doctor's visit by the kiosk or nurse clinician. Qualitative feedback will be captured via free-text inputs.
12 months
Health-related quality of life questionnaire
Periodo de tiempo: 12 months
Health-related quality of life will be assessed using the EQ-5D-5L questionnaire.
12 months

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

21 de junio de 2018

Finalización primaria (Anticipado)

1 de septiembre de 2019

Finalización del estudio (Anticipado)

1 de septiembre de 2019

Fechas de registro del estudio

Enviado por primera vez

4 de septiembre de 2017

Primero enviado que cumplió con los criterios de control de calidad

4 de septiembre de 2017

Publicado por primera vez (Actual)

6 de septiembre de 2017

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

26 de junio de 2018

Última actualización enviada que cumplió con los criterios de control de calidad

21 de junio de 2018

Última verificación

1 de junio de 2018

Más información

Términos relacionados con este estudio

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Ensayos clínicos sobre Kiosk intervention group

Suscribir